U.S. FDA·US·
FDA Seeks Public Input to Advance Development of Botanical Drug Products
The U.S. Food and Drug Administration today announced a request for information (RFI) to gather public input on opportunities to advance the development of botanical drug products.
More from U.S. FDA
- FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
- FDA Launches Expedited IND Pilot, Begins Accepting Applications
- FDA Takes Steps to Maintain Newborn Access to Life-Saving Starter Nutrition Products
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,200+ — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →Shared via PPN World — real-time press release intelligence.